1-4 of 4
Amy P Abernethy, MD PhD
Close
Sort by
Journal Articles

Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices

Thomas W. LeBlanc, MD MA, Catherine T Bloom, Debra M Davis, RN, Susan C Locke, PhD, Karen E Steinhauser, PhD, Peter A Ubel, MD, James A Tulsky, MD, Amy P Abernethy, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1280.
https://doi.org/10.1182/blood.V124.21.1280.1280
Published: 2014
Journal Articles

Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study

Thomas W. LeBlanc, MD MA, Cristina J Gasparetto, MD, Sascha A Tuchman, MD, Peter Sheldon, B.A., Alexandra Howson, PhD, Zeba M. Khan, PhD, Satyin Kaura, MSci, MBA, Amy P Abernethy, MD PhD
Journal: Blood
Blood (2014) 124 (21): 6010.
https://doi.org/10.1182/blood.V124.21.6010.6010
Published: 2014
Journal Articles

Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network

Thomas W. LeBlanc, MD, MA, Amy P Abernethy, MD, PhD, David J Casarett, MD, MA
Journal: Blood
Blood (2013) 122 (21): 1678.
https://doi.org/10.1182/blood.V122.21.1678.1678
Published: 2013
Journal Articles

Feasibility Study of a Dose Dense Induction Regimen of High Dose Cytarabine (HiDAC) and Gemtuzumab Ozogamicin (Mylotarg™) for Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia.

Arati V. Rao, MD, David A. Rizzieri, MD, Joseph O. Moore, MD, Carlos DeCastro, MD, Louis F. Diehl, MD, Amy P. Abernethy, MD, PhD, McLean Jordan, RN, Patty Davis, RN, Emily Edmonds, RN, Jon P. Gockerman, MD
Journal: Blood
Blood (2005) 106 (11): 4610.
https://doi.org/10.1182/blood.V106.11.4610.4610
Published: 2005